Pretreatment with Interferon-α2a Modulates Perioperative Immunodysfunction in Patients with Renal Cell Carcinoma

Publisher： Karger

E-ISSN： 2296-5262|31|1-2|28-34

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.31, Iss.1-2, 2008-01, pp. : 28-34

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

All-Trans Retinoic Acid and Interferon-α for Treatment of Human Renal Cell Carcinoma Multicellular Tumor Spheroids

By  

Urologia Internationalis, Vol. 73, Iss. 1, 2008-06 ,pp. : 47-53

Karger

Access to resources Recommend Favorite

Comparative Antitumor Activity of 5-Fluorouracil and 5’-Deoxy-5-Fluorouridine in Combination with Interferon-α in Renal Cell Carcinoma Cell Lines

By  

Urologia Internationalis, Vol. 73, Iss. 4, 2004-12 ,pp. : 348-353

Karger

Access to resources Recommend Favorite

Granulocyte-Macrophage Colony-Stimulating Factor and Interferon-Alpha 2B in Patients with Advanced Renal Cell Carcinoma

By  

Urologia Internationalis, Vol. 61, Iss. 4, 1999-06 ,pp. : 215-219

Karger

Access to resources Recommend Favorite

Neutralizing anti‐interferon‐α antibodies and response to treatment in patients with Ph+ chronic myeloid leukaemia sequentially treated with recombinant (α2a) and lymphoblastoid interferon‐α

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 2, 1996-08 ,pp. : 300-305

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neutralizing anti‐interferon‐α antibodies and response to treatment in patients with Ph+ chronic myeloid leukaemia sequentially treated with recombinant (α2a) and lymphoblastoid interferon‐α

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 2, 1996-08 ,pp. : 300-305

John Wiley & Sons Inc

Access to resources Recommend Favorite